Literature DB >> 19568711

A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria.

Trieu Nguyen Trung1, Bo Tan, Dang Van Phuc, Jian-ping Song.   

Abstract

OBJECTIVE: The study aimed to evaluate and compare the efficacy and safety of dihydroartemisinin-piperaquine phosphate (Artekin) and artemisinin-piperaquine (Artequick) in the treatment of uncomplicated falciparum malaria.
METHODS: A total of 103 uncomplicated falciparum malaria patients were enrolled and randomly assigned to two groups: 52 cases in the Artequick group, and 51 cases in the Artekin group. The patients in the Artequick group were administered with Artequick, twice in 24 h, whereas the patients in the Artekin group were given Artekin 4 times in 2 days. The mean parasite clearance time, mean fever clearance time, 28-day cure rate and parasite recrudescence rates of the two groups were then compared.
RESULTS: The mean parasite clearance time and the mean fever clearance time were 43.2+/-13.9 h and 24.7+/-9.9 h, in the Artequick group, and 36.5+/-17.1 h and 22.7+/-11.2 h, in the Artekin group. In both groups the 28-day cure rate was 100%, and the parasite recrudescence rate was 0.
CONCLUSION: Both medicines had high cure rates, low recrudescence rates, and no serious adverse reactions. The administration of Artequick, however, was more convenient and lower incidence of gastrointestinal side effects than that of Artekin, so as to increase the efficacy in the malaria population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19568711     DOI: 10.1007/s11655-009-0189-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  4 in total

1.  An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.

Authors:  N Tangpukdee; S Krudsood; W Thanachartwet; K Chalermrut; C Pengruksa; S Srivilairit; U Silachamroon; P Wilairatana; S Phongtananant; S Kano; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2005-09       Impact factor: 0.267

2.  Field observations on the antimalarial piperaquine.

Authors:  L Chen; F Y Qu; Y C Zhou
Journal:  Chin Med J (Engl)       Date:  1982-04       Impact factor: 2.628

3.  Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.

Authors:  Corine Karema; Caterina I Fanello; Chantal van Overmeir; Jean-Pierre van Geertruyden; Walli van Doren; Daniel Ngamije; Umberto D'Alessandro
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-06-12       Impact factor: 2.184

4.  Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.

Authors:  Tinh Hien Tran; Christiane Dolecek; Phuong Mai Pham; Thi Dung Nguyen; Thanh Truong Nguyen; Hong Thai Le; Thi Hoai An Dong; Tan Thanh Tran; Kasia Stepniewska; Nicholas J White; Jeremy Farrar
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

  4 in total
  12 in total

1.  Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.

Authors:  Sam Salman; Madhu Page-Sharp; Kevin T Batty; Kaye Kose; Susan Griffin; Peter M Siba; Kenneth F Ilett; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

Review 2.  Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.

Authors:  Adoke Yeka; Jamal C Harris
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

Review 3.  Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

4.  A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.

Authors:  Mayfong Mayxay; Sommay Keomany; Maniphone Khanthavong; Phoutthalavanh Souvannasing; Kasia Stepniewska; Tiengthong Khomthilath; Siamphay Keola; Tiengkham Pongvongsa; Samlane Phompida; David Ubben; Neena Valecha; Nicholas J White; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

5.  The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.

Authors:  Nguyen Xuan Thanh; Trieu Nguyen Trung; Nguyen Chinh Phong; Huynh Hong Quang; Bui Dai; G Dennis Shanks; Marina Chavchich; Michael D Edstein
Journal:  Malar J       Date:  2012-06-28       Impact factor: 2.979

6.  Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area.

Authors:  Jianping Song; Duong Socheat; Bo Tan; Suon Seila; Ying Xu; Fengzhen Ou; Sreng Sokunthea; Leap Sophorn; Chongjun Zhou; Changsheng Deng; Qi Wang; Guoqiao Li
Journal:  Malar J       Date:  2011-08-10       Impact factor: 2.979

7.  Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study.

Authors:  Tran Tinh Hien; Warunee Hanpithakpong; Nguyen Thanh Truong; Nguyen Thi Dung; Pham Van Toi; Jeremy Farrar; Niklas Lindegardh; Joel Tarning; Michael Ashton
Journal:  Clin Ther       Date:  2011-05       Impact factor: 3.393

8.  Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers.

Authors:  Sofia Birgersson; Pham Van Toi; Nguyen Thanh Truong; Nguyen Thi Dung; Michael Ashton; Tran Tinh Hien; Angela Abelö; Joel Tarning
Journal:  Malar J       Date:  2016-02-16       Impact factor: 2.979

9.  Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: A network meta-analysis.

Authors:  Cho Naing; Maxine A Whittaker; Norah Htet Htet; Saint Nway Aye; Joon Wah Mak
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

10.  Adherence to Mass Drug Administration with Dihydroartemisinin-Piperaquine and Plasmodium falciparum Clearance in Southern Province, Zambia.

Authors:  Timothy P Finn; Travis R Porter; Hawela Moonga; Kafula Silumbe; Rachel F Daniels; Sarah K Volkman; Joshua O Yukich; Joseph Keating; Adam Bennett; Richard W Steketee; John M Miller; Thomas P Eisele
Journal:  Am J Trop Med Hyg       Date:  2020-08       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.